ahlam1399
09-03-2015, 12:01 PM
UPDATE 1-**vartis makes history with U.S. launch of ?biosimilar? drug
ZURICH/LONDON, Sept 3 (Reuters) - **vartis kicked off a new era in U.S. medicine on Thursday with the launch of the first "biosimilar" copy of a biotech**logy drug approved in the United States, following a green light from a U.S. appeals court.
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2.img (http://da.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/ach.htm)http://pi.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498810c4/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ysCPTLVuiyg:SvQk4u123QA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ysCPTLVuiyg:SvQk4u123QA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ysCPTLVuiyg
ZURICH/LONDON, Sept 3 (Reuters) - **vartis kicked off a new era in U.S. medicine on Thursday with the launch of the first "biosimilar" copy of a biotech**logy drug approved in the United States, following a green light from a U.S. appeals court.
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2.img (http://da.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/ach.htm)http://pi.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385181412/u/49/f/654213/c/35217/s/498810c4/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498810c4/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ysCPTLVuiyg:SvQk4u123QA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=ysCPTLVuiyg:SvQk4u123QA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=ysCPTLVuiyg:SvQk4u123QA:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/ysCPTLVuiyg